Funding news
RQ Biotechnology Ltd. logo

RQ Biotechnology Ltd. Raises $115.

Recently funded · $115.0M Series aHospitals and Health CareGBView source

Get the full RQ Biotechnology Ltd. company profile

Access contacts, investors, buying signals & more

Open in Dashboard

RQ Biotechnology, a company focused on making instant immunity a reality for vulnerable people, has closed a $115.0M Series A funding round. The substantial capital infusion will support its mission to develop potent, broad-spectrum monoclonal antibodies (mAbs) for infectious diseases where traditional vaccines may not be effective.

The passive immunization discovery company, which partners with pharmaceutical firms to bring its antibodies to market, secured investment from a syndicate including EQT Life Sciences, Frazier Life Sciences, Forbion, Monograph Capital, Wellington Management, and LifeArc Ventures. RQ Bio aims to provide instant and long-lasting protection against current and future viral infections.

I am excited to announce that EQT Life Sciences has participated in the $115 million Series A funding round for RQ Biotechnology Ltd. through one of its managed funds, alongside Frazier Life Sciences, Forbion, Monograph Capital, Wellington Management and LifeArc Ventures.

Influenza is often viewed as a manageable illness, but for immunocompromised and high-risk patients it can be severe and even fatal, while current options offer little reliable protection. RQ Bio is developing RQB01, a long-acting monoclonal antibody product designed to deliver potent, broad and season-long protection against influenza with a single administration. What attracted me to this compa

Unlock the full source

CEO quotes, investor details and growth metrics

Start free trial

Other United Kingdom companies recently funded

View all

Biggest recent Biotechnology rounds

Largest funding rounds in Biotechnology on Signalbase right now.

#CompanyAmount
1
Shockwave Medical logo

Shockwave Medical

United States

$13.1B
2
NeuroEM Therapeutics logo

NeuroEM Therapeutics

United States

$7.2B
3
GRAIL logo

GRAIL

United States

$7.1B
4
Illumina logo

Illumina

United States

$7.1B
5
RemeGen Biosciences logo

RemeGen Biosciences

United States

$5.6B

Other recent Series a rounds

Companies that recently closed a Series a round.

#CompanyAmount
1
Astral Systems logo

Astral Systems

United Kingdom

$30.2M
2
Omni Pet | B Corp™ logo

Omni Pet | B Corp™

United Kingdom

$13.8M
3
Silveray logo

Silveray

United Kingdom

$6.3M
4
Enlaye logo

Enlaye

United States

$9.5M
5
Maia Health logo

Maia Health

$15.0M